Drug Information

Drug General Information
Drug ID
D03BSK
Former ID
DIB010870
Drug Name
URC102
Indication Gout [ICD9: 274.00274.1274.8274.9; ICD10:M10] Phase 2 [524997]
Target and Pathway
Target(s) Solute carrier family 22 member 12 Target Info Inhibitor [550551]
WikiPathways Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
References
Ref 524997ClinicalTrials.gov (NCT02290210) Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients. U.S. National Institutes of Health.
Ref 550551Clinical pipeline report, company report or official report of Chugai Pharmaceutical (2013).